Stay updated on SRX246 in Huntington's Disease: Tolerability Clinical Trial
Sign up to get notified when there's something new on the SRX246 in Huntington's Disease: Tolerability Clinical Trial page.

Latest updates to the SRX246 in Huntington's Disease: Tolerability Clinical Trial page
- CheckyesterdayChange DetectedAdded a comprehensive list of study locations by state (AL, CA, CO, FL, GA, IL, KS, MA, MO, NY, OH, OR, PA, TN, TX, UT, VA, WA) and the Revision: v3.3.3. Removed the previous HHS Vulnerability Disclosure and the prior location list (v3.3.2).SummaryDifference2%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2.SummaryDifference0.0%

- Check37 days agoChange DetectedThe government funding/operating status notice was removed from the page. Core study information, including eligibility criteria, locations, and study details, remains unchanged.SummaryDifference0.3%

- Check52 days agoChange DetectedNo significant changes to core study information (purpose, design, eligibility criteria, or locations) were observed; the differences appear to be non-substantive metadata updates such as timestamps or layout adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check80 days agoChange DetectedCore content updated with a new operating-status notice and v3.2.0; a specific resource entry (Huntington disease) was removed, and v3.1.0 was deleted.SummaryDifference4%

- Check87 days agoChange DetectedCore content sections on drug safety and related topics were removed, and a new version tag v3.1.0 was added. This indicates content consolidation and a version upgrade with less emphasis on the previously listed drug-safety topics.SummaryDifference0.4%

Stay in the know with updates to SRX246 in Huntington's Disease: Tolerability Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SRX246 in Huntington's Disease: Tolerability Clinical Trial page.